ESMO 2017: Patients with High Risk Prostate Cancer May Benefit “Equally” From Two New Treatments
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new…
Patients with high risk prostate cancer starting long-term hormone therapy may benefit from two new…
Men who are tall and obese are at increased risk of high grade prostate cancer…
By Ian Haines, Monash University From the 1980s, when prostate screening became available, many men…
John Glover, Torrens University Australia Public health experts traditionally expect to see a very strong…
Tiny nanoparticles offer significant potential in detecting and treating disease, according to a new review.…
Researchers have shown for the first time how a class of advanced prostate cancer drugs…
Cancer is the disease group with the biggest impact on our health-costing us, as a…
Cancer experts and patient advocacy groups are using Men’s Health Week 2017 (12-18 June) to highlight…
A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a…
By Joe Sutton, Edinburgh Napier University Cancer treatment is often highly effective at first, yet patients’ tumours…